rabeprazole has been researched along with Renal Insufficiency in 1 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Renal Insufficiency: Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rabeprazole was well tolerated by both groups." | 2.69 | Rabeprazole: pharmacokinetics and tolerability in patients with stable, end-stage renal failure. ( Grimes, I; Humphries, TJ; Keane, WF; Swan, SK, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keane, WF | 1 |
| Swan, SK | 1 |
| Grimes, I | 1 |
| Humphries, TJ | 1 |
1 trial available for rabeprazole and Renal Insufficiency
| Article | Year |
|---|---|
Rabeprazole: pharmacokinetics and tolerability in patients with stable, end-stage renal failure.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Blood Cells; Blood Chemical Analysis | 1999 |